Realistic 1 year progress using Minoxidil, Dutasteride and Dermarolling 9/21/2026
The user shared their one-year progress using minoxidil, topical dutasteride, and dermarolling for hair regrowth, noting significant improvements in their hairline and beard growth. They recommend consistent use of these treatments for effective results.
View this post in the Community →
Similar Community Posts Join
5 / 5 resultscommunity 21 Dutasteride minoxidil and dermarolling 6 months results
The conversation discusses hair regrowth results using dutasteride, minoxidil, and dermarolling over six months. OP reports significant improvement, especially in the temples, by derma-rolling frequently and applying minoxidil afterward.
community Still losing ground slowly with Dutasteride + Minoxidil + Dermarolling + Nizoral over the course of 1.25 years of total treatment
The user is experiencing slow hair loss despite using Dutasteride, Minoxidil, Dermarolling, and Nizoral for 1.25 years and is considering further tests and treatments. They are also supplementing with vitamin D and iron and using a prescribed steroid cream.
community 6 months of dutasteride + minoxidil.
A 31-year-old male experienced significant hair regrowth after 6 months using daily 0.5 mg dutasteride, 5% topical minoxidil twice a day, occasional dermarolling, and hair supplements. He reported a slight decrease in libido initially but no other side effects, and there's potential for further improvement up to 12–18 months.
community 1 year on finasteride/minoxidil + dermarolling once a week
The user experienced significant hair thickening and temple hair growth after one year of using finasteride, minoxidil, and weekly dermarolling. They are considering asking their dermatologist about dutasteride.
community [24M] 6 YEAR FINASTERIDE/DUTASTERIDE+MINOXIDIL+HAIR TRANSPLANT RESULTS [PICTURES]
A 24-year-old shares their 6-year journey with hair loss treatments, including finasteride, dutasteride, oral and topical minoxidil, and a hair transplant of 2000 grafts. They report significant progress, especially in the last 2 years, with a routine of dutasteride, oral minoxidil, and weekly dermarolling.
Related Research
6 / 6 results
research Status of research on the development and regeneration of hair follicles
This review examines the mechanisms of hair follicle development and regeneration, discussing current hair loss treatments and emerging therapies like low-level laser therapy and stem cell therapy, which the authors suggest show promise in managing hair loss.
research Experimental and early investigational drugs for androgenetic alopecia
This review discusses current and emerging therapeutic strategies for androgenetic alopecia, noting limited evidence but suggesting areas such as prostaglandin analogs, PRP, and progenitor cell therapies as promising future directions.
research Effectiveness and Safety of Combined Therapy with Oral Minoxidil, Oral Dutasteride, and Mesotherapy with Dutasteride in Real Clinical Practice
This study found that combining oral minoxidil, oral dutasteride, and dutasteride mesotherapy was the most effective treatment for androgenetic alopecia, with improved outcomes at 12 months and a favorable safety profile, compared to other treatment combinations.
research The Use of Oral Dutasteride, Minoxidil, and Finasteride for Treating Endocrine Therapy-Induced Hair Loss from Breast Cancer Treatment: A Case Series Study
Oral dutasteride, minoxidil, and finasteride may help reduce hair loss in breast cancer survivors, but more research is needed.
research Mesotherapy: Dutasteride, Minoxidil, Vitamins
This review discusses the application of mesotherapy in dermatology and trichology, noting its potential benefits and issues, but reports no new clinical results.
research Comparative efficacy of oral dutasteride and low-, medium-, and high-dose oral minoxidil: a six-month prospective trichoscopic and clinical study
This study found that oral minoxidil was associated with short-term improvements in clinical severity for androgenetic alopecia, whereas oral dutasteride did not show significant early clinical changes in the six-month follow-up.